Enhancing Design & Characterization of LNPs to Penetrate & Treat Organ Specific Tumors

• Optimizing LNP design by leveraging targeting ligands for effective organ-specific delivery
• Overcoming physical barriers by addressing particle size limitations to improve penetration into the dense organ specific microenvironment
• Improving stability of targeted LNPs for robust delivery and treatment of oncological indications

Speakers:

Sandipan Dawn

Principal Scientist

Foghorn Therapeutics